Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers
- 6 December 2000
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (1) , 51-54
- https://doi.org/10.1016/s0960-894x(00)00596-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Synthesis of (E) and (Z)-Combretastatins A-4 and a Phenanthrene from Combretum caffrumSynthesis, 1999
- Antineoplastic Agents. 410. Asymmetric Hydroxylation of trans-Combretastatin A-4Journal of Medicinal Chemistry, 1999
- Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindleMedicinal Research Reviews, 1998
- Potent antimitotic and cell growth inhibitory properties of substituted chalconesBioorganic & Medicinal Chemistry Letters, 1998
- Preparation and Evaluation of Diarylalkynes as Antitumour AgentsSynthetic Communications, 1998
- The preclinical evaluation of angiogenesis inhibitorsInvestigational New Drugs, 1997
- Antineoplastic Agents. 291. Isolation and Synthesis of Combretastatins A-4, A-5, and A-6Journal of Medicinal Chemistry, 1995
- Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulinBiochemistry, 1989
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989
- Isolation, structure, and synthesis of combretastatin A-2, A-3, and B-2Canadian Journal of Chemistry, 1987